BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  AIT Therapeutics Announces Positive Preliminary Data for the Primary Endpoint of Safety in Its NO-NTM Abscessus Phase II Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

  The safety data, along with positive results in other key parameters, drive AIT’s decision to move the program forward and plan for a potential pivotal trial to begin in the United States in the second half of 2018.

  November 28, 2017

   · 

  8 min read
• Policy

  Aeterna Zentaris’ Marketing Authorization Application for Macrilen (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by EMA

  AGHD affects approximately 75,000 adults across the US, Canada and Europe.

  November 28, 2017

   · 

  5 min read
• 

  Business

  CIRCULOGENE Names Dr. Glen J. Weiss as CMO

  Dr. Weiss will oversee and advance the laboratory’s research efforts and further educate oncologists about CIRCULOGENE’s next-generation sequencing (NGS) technology.

  November 28, 2017

   · 

  3 min read
• Genetown

  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  The stock option vests 25% on the first anniversary of the grant date, with the remaining 75% to vest in monthly installments over the three years thereafter, and has a ten-year term.

  November 28, 2017

   · 

  1 min read
• Business

  Ascensia Diabetes Care and Health2Sync Announce Collaboration to Bring Digital Diabetes Management Solution to Patients In Asia

  As part of this collaboration, the companies will create a combined offering for people with diabetes that comprises of the CONTOUR PLUS or CONTOUR TS blood glucose monitoring systems from Ascensia, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program.

  November 28, 2017

   · 

  3 min read
• Genetown

  TESARO Announces Availability of VARUBI (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States

  The U.S. Food and Drug Administration (FDA) approved VARUBI injectable emulsion on October 25, 2017.

  November 28, 2017

   · 

  11 min read
• Business

  PhaseBio Enters Worldwide License Agreement With MedImmune for a Reversal Agent for Ticagrelor

  Ticagrelor is unique among P2Y12 antagonist antiplatelet agents due to its ability to reversibly bind to the receptor, whereas other P2Y12 antagonists bind permanently.

  November 28, 2017

   · 

  3 min read
• GN Store Nord A/S: Transactions in Relation to Share Buyback Program – Nov. 28, 2017

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  November 28, 2017

   · 

  2 min read
• Biotech Beach

  DeepRadiology Announces the World’s First CT Head System With Performance Exceeding Radiologists

  The system is able to detect clinically significant pathologies in CT scans of the head with error rates better than published error rates for radiologists.

  November 28, 2017

   · 

  1 min read
• Biotech Bay

  Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

  This advanced cell separation technology, known as Buoyancy-Activated Cell Separation, or BACS, is key to the ongoing development of Cesca’s CAR-TXpress™ platform.

  November 28, 2017

   · 

  4 min read